<DOC>
	<DOCNO>NCT01073566</DOCNO>
	<brief_summary>The purpose study evaluate Finesse , prandial insulin bolusing use conjunction basal insulin , achieve equivalent glycemic control compare multiple daily injection evaluate preference .</brief_summary>
	<brief_title>Feasibility Study Finesse Bolus Prandial Insulin Dosing Compared Multiple Daily Injections</brief_title>
	<detailed_description>The aim feasibility study compare efficacy , device satisfaction quality life ( QOL ) people type 1 2 diabetes deliver mealtime insulin use novel insulin bolus-patch ( Finesseâ„¢ ; Calibra Medical , Inc. , Redwood City , CA ) versus current device deliver bolus insulin ( pen/syringe ) . All subject inject basal insulin use current pen/syringe .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Diabetes mellitus intensive insulin therapy Insulin pump therapy Current use NPH regular insulin Severe hypoglycemic episode prior 6 month Unstable cardiac disease , hepatic , renal function</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Autoimmune Diseases</keyword>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Endocrine System Diseases</keyword>
	<keyword>Glucose Metabolism Disorders</keyword>
	<keyword>Immune System Diseases</keyword>
	<keyword>Insulin</keyword>
	<keyword>Metabolic Diseases</keyword>
</DOC>